Reported Reactions

Devices › Catheter, angioplasty, peripheral, transluminal

Device brand name · Peripheral dilatation catheter

Foxcross Pta Catheter: medical device reports filed with FDA

245 reports name it, 2009–2017. Manufacturer given most often on reports: Av-Temecula-Ct. Product code LIT.

245
device reports naming the brand
0% of all MAUDE reports · about 14 a year
0
reports, 12 months to August 2026
0 in the 12 months before
84.9%
classified as malfunction
83.5% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 245 reports that name the brand "Foxcross Pta Catheter" (peripheral dilatation catheter), received between April 2009 and March 2017; the manufacturer given most often on reports is Av-Temecula-Ct. Spellings of one product vary from report to report.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (84.9%) and injury (15.1%); across all catheter, angioplasty, peripheral, transluminal reports (product code LIT) death is recorded in 0.5% and malfunction in 83.5%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are material rupture (68.2%), difficult to remove (15.9%) and detachment of device component (11.4%). The patient problems coded most often are foreign body in patient, no patient involvement and intimal dissection. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Foxcross Pta Catheter was received in the five years to August 2026; the latest was received in March 2017.

By year received

030602009: 1220092010: 3420102011: 5620112012: 5220122013: 6020132014: 2520142015: 320152017: 32017

Event type and report source

Event type, as classified on the report

Death0%0
Injury15.1%37
Malfunction84.9%208
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%245
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 35,907 reports carrying product code LIT. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Material rupture16768.2%44.2%
Difficult to removethe device was hard to remove3915.9%9.1%
Detachment of device component2811.4%2.7%
Improper or incorrect procedure or method249.8%1.3%
Physical resistance187.3%0.8%
Balloon rupture166.5%7.4%
Deflation problem135.3%4.5%
Leak/splashthe device leaked124.9%6.1%
Folded83.3%0.2%
Inflation problem83.3%4.1%
Difficult to position62.4%0.4%
Failure to advance41.6%1.3%
Source, detachment from31.2%0.9%
Component falling20.8%0%
Crackthe device cracked20.8%0.3%
Defective devicethe device was defective20.8%0.1%
Breakthe device broke10.4%3.2%
Device contamination with chemical or other material10.4%0.2%
Device damaged by another device10.4%0.2%
Device misassembled during manufacturing /shipping10.4%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Foreign body in patientpart of a device left in the patient72.9%
No patient involvement52%
Intimal dissection31.2%
Device embedded in tissue or plaque10.4%
Fistula10.4%
Foreign body, removal of10.4%
Nonresorbable materials, unretrieved in body10.4%
Perforation10.4%
Surgical procedure10.4%
Therapy/non-surgical treatment, additional10.4%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureFoxcross Pta CatheterProduct code LITAll MAUDE reports
Reports24535,90726,136,888
Share of that pool—0.7%0%
Classified as death, per 1,000 reports059
Classified as injury15.1%15.1%36.2%
Classified as malfunction84.9%83.5%62.3%
Filed by the manufacturer100%97.6%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code LIT

BrandReportsLatest 12 monthsClassified as death
Coyote? ES5,4284380%
2cm Peripheral Cutting Balloon3,2023140%
Armada 35 PTA Catheter1,86490.2%
Sterling4,9633000.1%
Coyote?1,7671220.1%
Mustang5,9694910.3%
Armada 18 Pta Catheter65100%
Armada6803050.1%
Gladiator? Elite545590%
Armada 14 Pta Catheter74600%
Ultra-Thin Balloon Dilatation Catheter48800.4%
Fox Plus Pta Catheter38500%
Ultraverse RX369680%
Evercross 035427302.6%
Sterling Es Pta Balloon Dilatation Catheter33300%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Foxcross Pta Catheter reports

How many FDA reports name Foxcross Pta Catheter?

245 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

malfunction (84.9%) and injury (15.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

material rupture (68.2%), difficult to remove (15.9%), detachment of device component (11.4%), improper or incorrect procedure or method (9.8%) and physical resistance (7.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Foxcross Pta Catheter was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.